Product
Human Papillomavirus 9-valent Vaccine
2 clinical trials
3 indications
Indication
meningococcal immunizationIndication
Healthy Control ParticipantsIndication
WartsClinical trial
Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine Versus Nimenrix®, and When Administered Alone or Concomitantly With 9vHPV and Tdap-IPV Vaccines in Healthy AdolescentsStatus: Completed, Estimated PCD: 2022-05-11
Clinical trial
Human Papillomavirus (HPV) Vaccination for the Treatment of Refractory Cutaneous Warts: A Randomized, Placebo-Controlled, Double-Blinded TrialStatus: Recruiting, Estimated PCD: 2025-12-01